[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.120.181. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News & Perspectives
October 2, 2013

Malaria Vaccine, Ebola Therapy Promising in Early Studies

JAMA. 2013;310(13):1327-1328. doi:10.1001/jama.2013.278188

After years of work on efforts to control 2 major tropical diseases, researchers have reported important developments that may lead to a malaria vaccine and a treatment for Ebola virus infection.

One team of researchers demonstrated in a small, preliminary trial that intravenous injections of purified cryopreserved Plasmodium falciparum sporozoites can successfully protect individuals against malaria infection. A second group found in a small study in rhesus macaques that a cocktail of monoclonal antibodies derived from plants may substantially reduce the risk of death from Ebola, even after clinical symptoms appear.

First Page Preview View Large
First page PDF preview
First page PDF preview
×